Cargando…
Targeting MCF-7 Cell Line by Listeriolysin O Pore Forming Toxin Fusion with AHNP Targeted Peptide
BACKGROUND: Tumor-targeting peptides are attracting subjects in cancer therapy. These peptides, which are widely studied, deliver therapeutic agents to the specific sites of tumors. In this study, we produced a new form of recombinant listeriolysin O (LLO) with genetically fused Anti-HER2/neu peptid...
Autores principales: | Fotoohi-Ardakani, Gholamreza, Kheirollahi, Majid, Zarei Jaliani, Hossein, Noorian, Mohadese, Ansariniyia, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543864/ https://www.ncbi.nlm.nih.gov/pubmed/31259162 http://dx.doi.org/10.4103/abr.abr_18_19 |
Ejemplares similares
-
Recombinant Production of a Novel Fusion Protein: Listeriolysin O Fragment Fused to S1 Subunit of Pertussis Toxin
por: Forghani, Hossein, et al.
Publicado: (2021) -
Recombinant production and affinity purification of the FraC pore forming toxin using hexa-His tag and pET expression cassette
por: Imani, Mehdi, et al.
Publicado: (2017) -
Evaluating cytotoxic effects of recombinant fragaceatoxin C pore forming toxin against AML cell lines
por: Azadpour, Mahnaz, et al.
Publicado: (2018) -
Rapid Remodeling of the Host Epithelial Cell Proteome by the Listeriolysin O (LLO) Pore-forming Toxin
por: Malet, Julien Karim, et al.
Publicado: (2018) -
pH-triggered endosomal escape of pore-forming Listeriolysin O toxin-coated gold nanoparticles
por: Plaza-GA, Ismael, et al.
Publicado: (2019)